Valuation: Vitrolife AB

Market Cap 15.64B 1.55B 1.41B 1.3B 1.17B 2.21B 146B 2.29B 6.2B 78.21B 5.83B 5.7B 248B P/E 2026 *
32.1x
P/E 2027 * 25.4x
Enterprise Value 16.4B 1.63B 1.48B 1.36B 1.23B 2.32B 154B 2.4B 6.5B 82.02B 6.11B 5.98B 260B EV / Sales 2026 *
4.67x
EV / Sales 2027 * 4.14x
Free-Float
54.39%
Yield 2026 *
0.94%
Yield 2027 * 1.11%
1 day+1.10%
1 week-0.75%
Current month+3.20%
1 month+20.89%
3 months+29.78%
6 months+13.52%
Current year-12.99%
1 week 116.3
Extreme 116.3
122.8
1 month 95.55
Extreme 95.55
122.8
Current year 84
Extreme 84
139.6
1 year 84
Extreme 84
152.5
3 years 84
Extreme 84
268
5 years 84
Extreme 84
573
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 55 01/11/2026
Director of Finance/CFO 55 10/10/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 63 19/04/2013
Chairman 70 01/08/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap. Importance
6/2/26 Buy

Chief Operating Officer

6,470 0.0048%
6/2/26 Buy

Chief Executive Officer

3,013 0.0022%
4/2/26 Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+1.19%-0.75%-15.76%-23.10% 1.56B
+1.40%-1.02%-15.82%+13.59% 186B
+1.89%+1.07%+7.02%+42.74% 124B
-1.34%-5.60%-17.62%+9.15% 119B
+1.36%-5.91%-43.00%+3.16% 91.43B
+2.54%+6.76%-2.55%+79.07% 66.67B
+0.96%+2.91%+12.95%-7.56% 58.76B
+0.92%+4.16%+0.38%+62.86% 54.99B
-0.68%-0.62%-2.41%+56.27% 49.93B
+1.04%+2.04% - - 35.13B
Average +0.90%-1.99%-8.53%+26.24% 79B
Weighted average by Cap. +0.92%-3.36%-10.15%+26.93%

Financials

2026 *2027 *
Net sales 3.51B 349M 316M 292M 264M 497M 32.88B 515M 1.39B 17.56B 1.31B 1.28B 55.75B 3.83B 380M 344M 319M 287M 542M 35.84B 561M 1.52B 19.14B 1.43B 1.4B 60.77B
Net income 495M 49.13M 44.52M 41.18M 37.16M 70.02M 4.63B 72.49M 196M 2.47B 184M 180M 7.86B 620M 61.55M 55.78M 51.59M 46.55M 87.72M 5.8B 90.81M 246M 3.1B 231M 226M 9.84B
Net Debt 762M 75.63M 68.54M 63.39M 57.2M 108M 7.13B 112M 302M 3.81B 284M 278M 12.09B 225M 22.34M 20.24M 18.72M 16.89M 31.83M 2.11B 32.96M 89.18M 1.13B 83.82M 82.04M 3.57B
Projected Income Statement - Annual - Vitrolife AB
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,088
Date Price Change Volume
14/11/26 SEK 119.20 +1.19% 157,094
12/11/26 SEK 117.80 -0.42% 198,434
11/11/26 SEK 118.30 +0.08% 146,345
10/11/26 SEK 118.20 -1.17% 206,792
09/11/26 SEK 119.60 -0.42% 321,040
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Vitrolife AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
117.80SEK
Average target price
133.00SEK
Spread / Average Target
+12.90%
  1. Stock Market
  2. Stocks
  3. VITR Stock